Canadian VIGOUR Centre
@cvcualberta.bsky.social
44 followers 120 following 10 posts
The Canadian VIGOUR Centre (CVC) is an academic research organization at the University of Alberta dedicated to enhancing cardiovascular health.
Posts Media Videos Starter Packs
cvcualberta.bsky.social
❣️The Fall 2025 issue of the CVC Chronicle newsletter is now available❣️

Read about our current trials, research highlights, & other recent news/updates here: tinyurl.com/3w4srx67
Reposted by Canadian VIGOUR Centre
turbodc.bsky.social
Dr. Moorthy reviewing the WHO global action plan for clinical trial ecosystem strengthening at the 4th Annual ACT meeting in Cape Breton, NS. We are making progress in Canada but lots of work to do!
@cvcualberta.bsky.social @csnscn.bsky.social @ualberta.bsky.social
cvcualberta.bsky.social
New analysis published in @jcardfail.bsky.social: applying the 5-STAR risk stratification method to VICTORIA trial data revealed a greater treatment effect for vericiguat on the composite endpoint of CV death or HF hospitalization.

Read more ➡️: authors.elsevier.com/a/1llYy3pkRz...
Reposted by Canadian VIGOUR Centre
albertaphdoc.bsky.social
Happy to have had the chance to contribute to this amazing collaborative work led by @sandeepsahaymd.bsky.social and Dr Ray Benza
ishlt.bsky.social
📢 A NEW #ISHLT Consensus Statement on risk stratification in pulmonary arterial hypertension (#PAH) is now available. Check out the top 5️⃣ takeaways ⏬ & read the publication at 🔗 bit.ly/4lXTrLd
Reposted by Canadian VIGOUR Centre
thelancet.com
Heart failure affects more than 55 million people worldwide. 🫀

A new Lancet Series, presented at #ESC2025, serves as a call to action for clinicians, health systems, and governments to prioritise the primary prevention of heart failure. tinyurl.com/2sty9386
Figure highlighting selected opportunities for promotion of CKM health and prevention of heart failure at the individual, health-care system and community, and population and policy levels. CKM=cardiovascular-kidney-metabolic. Copyright: 2025 Elsevier Ltd. All rights reserved.
Reposted by Canadian VIGOUR Centre
accintouch.bsky.social
Late-breaking science from VICTOR & VICTORIA trials presented at #ESCCongress add to growing body of evidence surrounding vericiguat in treating patients with HFrEF. Read more: https://bit.ly/4lTUNXE
#HeartFailure
Reposted by Canadian VIGOUR Centre
jaccjournals.bsky.social
In #HFrEF, quadruple therapy (ARNi, β-blockers, MRA, #SGLT2i) improves survival. Adding #vericiguat may offer a modest ~0.7-year gain, though findings are exploratory, as they are derived from a secondary endpoint of a single trial https://bit.ly/4mE83Rp

#JACC #ESCCongress #WCCardio
cvcualberta.bsky.social
The AURORA study is currently recruiting adults & adolescents with type 1 diabetes (T1D) & caregivers for an advisory group. Share your experience navigating the Alberta healthcare system & help us create a vital T1D knowledge hub!

Learn more ➡️: thecvc.ca/aurora-recru...
Reposted by Canadian VIGOUR Centre
tctmd.bsky.social
Patients hospitalized with influenza are just as likely as COVID-19 patients to have signs of myocardial involvement. Lead study author Finlay McAlister said the findings show a need to screen and monitor patients more closely. www.tctmd.com/news/cardiac...
Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza
Patients who are hospitalized for either viral infection should be screened for myocardial involvement, experts say.
www.tctmd.com
cvcualberta.bsky.social
New in @jaccjournals.bsky.social: A secondary analysis of the VICTORIA trial investigates the impact of geographic variation and Human Development Index on heart failure outcomes. 🫀 🌏

Read more here: www.sciencedirect.com/science/arti...
Reposted by Canadian VIGOUR Centre
cjcjournals.bsky.social
💭 Review of transcatheter aortic valve insertion (#TAVI) clinician opinions on the CCS Post-TAVI Driving Guidelines: is a 1-month driving restriction period overly cautious? Read more ⬇️
cjcopen.ca/article/S258...
#CJCO #OpenAccess
Reposted by Canadian VIGOUR Centre
jamanetworkopen.com
Among patients with opioid-associated out-of-hospital cardiac arrest, chest compression and ventilation CPR was associated with a higher odds of favorable neurologic outcomes at hospital discharge.

ja.ma/4l7We4q
Reposted by Canadian VIGOUR Centre
phaware.bsky.social
Dr. Jason Weatherald explains how your everyday clinic visits can help shape the future of pulmonary hypertension treatment. @phaware.bsky.social podcast ep 524 @phacanada #phawareMD @teamphhope @albertaphdoc.bsky.social @ualberta.bsky.social medium.com/p/im-aware-t...
I’m Aware That I’m Rare: Jason Weatherald, MD (524)
the phaware® interview
medium.com
Reposted by Canadian VIGOUR Centre
ccs-scc.bsky.social
🫀 Join us June 11 for our webinar: Heart-Healthy Eating: Evidence-Based Nutrition for Cardiovascular Health!

🔗 Register now! ow.ly/yBOO50W5aZP

#cardiosky
cvcualberta.bsky.social
Dr. Padma Kaul will lead a #OneChildEveryChild program exploring how clinical, genetic, socio-economic, & behavioral factors impact neonatal & early childhood outcomes following pregnancy complications. @wchriuofa.bsky.social

Read more about the OCEC initiative ⬇️

www.ucalgary.ca/news/ucalgar...
UCalgary experts investigate effects of climate change on child health, and possible solutions
Transdisciplinary project one of six research programs announced by One Child Every Child initiative
www.ucalgary.ca
cvcualberta.bsky.social
❣️The Spring 2025 issue of the CVC Chronicle newsletter is now available ❣️

Read about our current trials, research highlights, & other recent news/updates here: mailchi.mp/3fed258d1c05...
cvcualberta.bsky.social
New research: Women with asthma, particularly active asthma, are at higher risk for preterm birth, low birth weight, & C-section. These findings highlight the need for improved asthma monitoring & management during pregnancy. @wchriuofa.bsky.social

Read here: www.sciencedirect.com/science/arti...
cvcualberta.bsky.social
Featured CJC Open article from CVC authors highlights the substantial and likely rising cost of heart failure hospitalizations in Canada, underscoring the urgent need for strategic solutions.

Read here ▶️: www.cjcopen.ca/article/S258...

#HeartFailureWeekCan
ccs-scc.bsky.social
Looking for resources in honour of Heart Failure Awareness Week 2025? Don’t miss our curated collection of articles from CCS Journals available here: ccs.ca/wp-content/u...
Reposted by Canadian VIGOUR Centre
criticalcummute.bsky.social
🌟 New Episode Alert 🌟 Dive into extracorporeal life support (ECLS) with Dr. Sean van Diepen at the Critical Care Canada Forum. Tune in to explore cutting-edge insights from the DANGER and ECLS-SHOCK trials!
Listen here: open.spotify.com/episode/4Pka...
Extracorporeal Support in Cardiogenic Shock - A Look at the Evidence with Dr Sean van Diepen
The Critical Care Commute Podcast · Episode
open.spotify.com
Reposted by Canadian VIGOUR Centre
ccs-scc.bsky.social
Join our ASCVD Management webinar tonight! 🩺 Complex case studies included!

Register now: my.ccs.ca/CCSMembers/T...
cvcualberta.bsky.social
We are pleased to share our 2024 Annual Report: ⚙️Research in Motion⚙️

The CVC is committed to advancing cardiovascular research, recognizing that each step in the process drives meaningful developments & enhances health outcomes for current & future generations.

Read here: thecvc.ca/2024-annual-...